Performance and comparison of assessment models to predict 30-day mortality in patients with hospital-acquired pneumonia

被引:9
作者
Wen, Jia-Ning [1 ]
Li, Nan [2 ]
Guo, Chen-Xia [1 ]
Shen, Ning [1 ]
He, Bei [1 ]
机构
[1] Peking Univ Third Hosp, Dept Resp Med, Beijing 100191, Peoples R China
[2] Peking Univ Third Hosp, Res Ctr Clin Epidemiol, Beijing 100191, Peoples R China
关键词
Hospital-acquired pneumonia; Mortality; Sequential Organ Failure Assessment (SOFA); Acute Physiology and Chronic Health Evaluation II (APACHE II); Quick Sequential Organ Failure Assessment (qSOFA); INTERNATIONAL CONSENSUS DEFINITIONS; VENTILATOR-ASSOCIATED PNEUMONIA; SEPTIC SHOCK; CLINICAL-CRITERIA; APACHE-II; SEVERITY; SEPSIS; MANAGEMENT; SCORES; SOFA;
D O I
10.1097/CM9.0000000000001252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hospital-acquired pneumonia (HAP) is the most common hospital-acquired infection in China with substantial morbidity and mortality. But no specific risk assessment model has been well validated in patients with HAP. The aim of this study was to investigate the published risk assessment models that could potentially be used to predict 30-day mortality in HAP patients in non-surgical departments. Methods This study was a single-center, retrospective study. In total, 223 patients diagnosed with HAP from 2012 to 2017 were included in this study. Clinical and laboratory data during the initial 24 hours after HAP diagnosis were collected to calculate the pneumonia severity index (PSI); consciousness, urea nitrogen, respiratory rate, blood pressure, and age >= 65 years (CURB-65); Acute Physiology and Chronic Health Evaluation II (APACHE II); Sequential Organ Failure Assessment (SOFA); and Quick Sequential Organ Failure Assessment (qSOFA) scores. The discriminatory power was tested by constructing receiver operating characteristic (ROC) curves, and the areas under the curve (AUCs) were calculated. Results The all-cause 30-day mortality rate was 18.4% (41/223). The PSI, CURB-65, SOFA, APACHE II, and qSOFA scores were significantly higher in non-survivors than in survivors (all P < 0.001). The discriminatory abilities of the APACHE II and SOFA scores were better than those of the CURB-65 and qSOFA scores (ROC AUC: APACHE II vs. CURB-65, 0.863 vs. 0.744, Z = 3.055, P = 0.002; APACHE II vs. qSOFA, 0.863 vs. 0.767, Z = 3.017, P = 0.003; SOFA vs. CURB-65, 0.856 vs. 0.744, Z = 2.589, P = 0.010; SOFA vs. qSOFA, 0.856 vs. 0.767, Z = 2.170, P = 0.030). The cut-off values we defined for the SOFA, APACHE II, and qSOFA scores were 4, 14, and 1. Conclusions These results suggest that the APACHE II and SOFA scores determined during the initial 24 h after HAP diagnosis may be useful for the prediction of 30-day mortality in HAP patients in non-surgical departments. The qSOFA score may be a simple tool that can be used to quickly identify severe infections.
引用
收藏
页码:2947 / 2952
页数:6
相关论文
共 50 条
  • [41] Population Pharmacokinetic/Pharmacodynamic Study of Linezolid in Hospital-Acquired Pneumonia Patients with Renal Insufficiency
    Xu, Jinhui
    Chen, Xianglong
    Zhang, Qian
    Zhuang, Zhiwei
    Yuan, Yunlong
    Duan, Lufen
    Shi, Lu
    Zhu, Chenqi
    Li, Jingjing
    Lu, Jian
    Yu, Yanxia
    Tang, Lian
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 5073 - 5086
  • [42] Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice
    Kouroupis, Pompeo Costantino
    O'Rourke, Niall
    Kelly, Sinead
    McKittrick, Myles
    Noppe, Elne
    Reyes, Luis F.
    Rodriguez, Alejandro
    Martin-Loeches, Ignacio
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (06) : 423 - 433
  • [43] Ventilator-Associated Pneumonia: Epidemiology and Prognostic Indicators of 30-Day Mortality
    Inchai, Juthamas
    Pothirat, Chaicharn
    Liwsrisakun, Chalerm
    Deesomchok, Athavudh
    Kositsakulchai, Weerayut
    Chalermpanchai, Nipon
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2015, 68 (03) : 181 - 186
  • [44] A new method to predict hospital mortality in severe community acquired pneumonia
    Wang, Xin
    Jiao, Jianlong
    Wei, Rongwei
    Feng, Yongli
    Ma, Xiuqin
    Li, Yuan
    Du, Yue
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 40 : 56 - 63
  • [45] Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia
    Xu, Li
    Wang, Ya-Li
    Du, Shuai
    Chen, Lin
    Long, Li-Hui
    Wu, Yan
    CHEMOTHERAPY, 2015, 61 (06) : 323 - 330
  • [46] Hospital-acquired pneumonia in patients receiving immunosuppressive therapy
    Edis, Ebru Cakir
    Hatipoglu, Osman Nuri
    Yilmam, Ilker
    Eker, Alper
    Tansel, Ozlem
    Sut, Necdet
    Tekgunduz, Emre
    Demir, Muzaffer
    TURKISH JOURNAL OF HEMATOLOGY, 2010, 27 (01) : 20 - 24
  • [47] PREDICTORS OF MORTALITY IN INDONESIAN PATIENTS WITH HOSPITAL ACQUIRED PNEUMONIA
    Halim, Samuel
    Amin, Zulkifli
    Chen, Khie
    Nugroho, Pringgodigdo
    RESPIROLOGY, 2013, 18 : 44 - 44
  • [48] Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
    Freire, Antonio T.
    Melnyk, Vasyl
    Kim, Min Ja
    Datsenko, Oleksiy
    Dzyublik, Oleksandr
    Glumcher, Felix
    Chuang, Yin-Ching
    Maroko, Robert T.
    Dukart, Gary
    Cooper, C. Angel
    Korth-Bradley, Joan M.
    Dartois, Nathalie
    Gandjini, Hassan
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 68 (02) : 140 - 151
  • [49] Hospital-acquired pneumonia incidence and diagnosis in older patients
    Burton, Louise A.
    Price, Rosemary
    Barr, Karen E.
    McAuley, Sean M.
    Allen, Jennifer B.
    Clinton, Aoibhinn M.
    Phillips, Gabby
    Marwick, Charis A.
    McMurdo, Marion E. T.
    Witham, Miles D.
    AGE AND AGEING, 2016, 45 (01) : 171 - 174
  • [50] Factors Associated With 30-Day Rehospitalization and Mortality in Older Patients After a Pneumonia Admission
    Graversen, Susanne B.
    Pedersen, Henrik S.
    Sandbaek, Annelli
    Foss, Catherine H.
    Ribe, Anette R.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (12) : 1869 - +